Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CMND
#5255
Clearmind Medicine Inc. Common Shares
0.9
1
USD
-36.36%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-36.36%
Monthly Change
+18.18%
6 month change
-3.19%
Year Change
-2.15%
Previous Close
1.4
3
Open
0.9
1
Bid
Ask
Low
0.9
1
High
0.9
1
Volume
4
Markets
US Stock Market
Healthcare
CMND
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2022
2023
2024
2025
Total assets
—
5.95 M
7.26 M
6.08 M
Total liabilities
—
4.97 M
4.15 M
4.89 M
Total equity
—
983.47 K
3.11 M
1.19 M
Total liabilities & shareholders' equities
—
5.95 M
7.26 M
6.08 M
Total debt
—
—
—
—
Net debt
—
—
—
—
News
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.66%
Clearmind Medicine secures six patents in Hong Kong
Clearmind files Hong Kong patent for depression treatment combo
Clearmind advances enrollment in alcohol disorder drug trial
Clearmind files patent for obesity, liver disease treatment combo
Clearmind gets safety board approval to continue AUD trial
Clearmind Medicine stock falls after Phase I/IIa trial safety update
Clearmind reports positive safety results in AUD drug trial
Clearmind reports positive safety data from AUD treatment trial
Clearmind Medicine stock surges after Polyrizon intranasal delivery deal
Clearmind partners with Polyrizon to develop intranasal MEAI formulation
Polyrizon to develop intranasal formulation of Clearmind’s MEAI drug